Atezolizumab and bevacizumab with transarterial chemoembolization in hepatocellular carcinoma: the DEMAND trial protocol.
第一作者:
Najib,Ben Khaled
第一单位:
Department of Medicine II, University Hospital, LMU Munich, Munich, 81377, Germany.
作者:
主题词
抗肿瘤联合化疗方案(Antineoplastic Combined Chemotherapy Protocols);癌, 肝细胞(Carcinoma, Hepatocellular);化学栓塞, 治疗性(Chemoembolization, Therapeutic);临床试验, Ⅱ期(主题)(Clinical Trials, Phase II as Topic);人类(Humans);肝肿瘤(Liver Neoplasms);多中心研究(主题)(Multicenter Studies as Topic);生活质量(Quality of Life);随机对照试验(主题)(Randomized Controlled Trials as Topic)
DOI
10.2217/fon-2021-1261
PMID
35081747
发布时间
2024-03-27
- 浏览0

Future oncology (London, England)
1423-1435页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文